Cargando…

Anti-TNF-α agents Modulate SARS-CoV-2 Receptors and Increase the Risk of Infection Through Notch-1 Signaling

Although millions of patients with underlining conditions are treated primarily with anti-TNF-α agents, little is known about the safety of this standard therapy during the coronavirus disease-2019 (COVID-19) pandemic. In this study, we investigated the effect of anti-TNF-α monoclonal antibodies on...

Descripción completa

Detalles Bibliográficos
Autores principales: Keewan, Esra’a, Beg, Shazia, Naser, Saleh A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134694/
https://www.ncbi.nlm.nih.gov/pubmed/34025650
http://dx.doi.org/10.3389/fimmu.2021.641295

Ejemplares similares